The vaccines division of sanofi aventis group. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the ...

Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.

Year to date, shares of Sanofi have lost 4% against the industry’s growth of 1.4%. Image Source: Zacks Investment Research Per the expanded collaboration agreement, Sanofi and SK bioscience will ...